Last Week in GER Research: Topsports, Bitauto, Cloudminds, Manulife, Maple Ind. Trust and Budweiser
Below is a recap of the key IPO and event-driven research produced by the Global Equity Research team. This week, we assess the IPO prospects for...
547 Views
China Biologic's Privatisation Redux
On Wednesday after market close, China Biologic Products (CBPO US) announced a surprising privatisation bid from a consortium for $120 per ADS. The...
596 Views
Vital Fluids: Proposal Rejuvenates China Biologics
On the 19 June last year, CITIC Capital Holdings made an unsolicited, preliminary non-binding proposal for China Biologic Products (CBPO US) - a...
625 Views
Global Equity Strategy: Another Test of Support
Heightened trade tensions have caused global equities to move from resistance to support in a matter of days. Additional consolidation - i.e., no...
453 Views
China Blood Products: Deals Highlight Values
Grifols SA (GRF SM) and Shanghai RAAS Blood Products Co Ltd (002252.SZ) recently announced an asset exchange that effectively combines the...
672 Views